Setmelanotide
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
Rhythm · Phase 2 · Completed · Enrollment 74
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Setmelanotide | 5 participants | 0 participants | 1 participants | n/r | 0 |
| Placebo | 3 participants | 2 participants | 0 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.